• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background

    Fetal Macrosomia Companies

    ID: MRFR/Pharma/2685-HCR
    79 Pages
    Rahul Gotadki
    October 2025

    Companies dedicated to fetal macrosomia address the challenges associated with large fetal size during pregnancy. They focus on research, development, and solutions aimed at managing and preventing complications related to excessive fetal growth, ensuring the well-being of both mother and baby.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Fetal Macrosomia Market

    Fetal Macrosomia Key Companies

    Latest Fetal Macrosomia Companies Update



    Philips acquires iSchemaView for $225 million deal strengthens Philips' imaging portfolio, adding iSchemaView's AI-powered fetal growth assessment tools to their arsenal for earlier and more accurate detection of potential macrosomia cases.


    Viz.ai and GE Healthcare are developing AI algorithms that analyze ultrasound images, potentially identifying babies at risk of macrosomia with greater accuracy.


    Volpara Health and FetalMetrics are creating devices and software that utilize maternal measurements and ultrasound data to provide more precise fetal weight estimates, aiding in managing macrosomia risks.


    List of Fetal Macrosomia Key Companies in the Market



    • Carestream Health (US)

    • Esaote SpA (Italy)

    • Fonar Corporation (US)

    • Fujifilm Holdings Corporation (Japan)

    • GE Healthcare (UK)

    • Hitachi Medical Corporation (Japan)

    • Hologic Inc. (US)

    • Philips Healthcare (Netherlands)

    • Samsung Medison Co. Ltd (Republic of Korea)

    • Shimadzu Corporation (Japan)

    • Siemens Healthcare (Germany)

    • Toshiba Corporation (Japan)